Advances in the critical care management of ischemic stroke

Stroke Research and Treatment

Volumn , Issue , 2013, Pages

  Singh, Vineeta ^a   Edwards, Nancy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIHISTAMINIC AGENT; CANDESARTAN; CORTICOSTEROID; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; LABETALOL; NICARDIPINE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DECOMPRESSIVE CRANIECTOMY; DRUG DOSE TITRATION; DRUG EFFICACY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTHERMIA; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE MONITORING; PRIORITY JOURNAL; REVIEW; THERMOREGULATION;

EID: 84878678457     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2013/510481     Document Type: Review

References (33)

1. Zazulia A. R., Critical care management of acute ischemic stroke. Continuum Lifelong Learning in Neurology 2009 15 3 68 82 2-s2.0-78650752285 10.1212/01.CON.0000348810.14427.c5
2. Diringer M. N., Edwards D. F., Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Critical Care Medicine 2001 29 3 635 640 2-s2.0-0035100660 (Pubitemid 32225309)
3. Bershad E. M., Feen E. S., Hernandez O. H., Suri M. F. K., Suarez J. I., Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients. Neurocritical Care 2008 9 3 287 292 2-s2.0-58849108654 10.1007/s12028-008-9051-5
4. Broderick J. P., Palesch Y. Y., Demchuk A. M., Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine 2013 368 10 893 903 10.1056/NEJMoa1214300
5. Ciccone A., Valvassori L., Nichelatti M., Endovascular treatment for acute ischemic stroke. The New England Journal of Medicine 2013 368 10 904 913 10.1056/NEJMoa1213701
6. Albers G. W., Bates V. E., Clark W. M., Bell R., Verro P., Hamilton S. A., Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Journal of the American Medical Association 2000 283 9 1145 1150 2-s2.0-0034161354 (Pubitemid 30126602)
7. Hill M. D., Buchan A. M., Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005 172 10 1307 1312 2-s2.0-19744368662 10.1503/cmaj.1041561 (Pubitemid 40745072)
8. Lees K. R., Bluhmki E., von Kummer R., Brott T. G., Toni D., Grotta J. C., Albers G. W., Kaste M., Marler J. R., Hamilton S. A., Tilley B. C., Davis S. M., Donnan G. A., Hacke W., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010 375 9727 1695 1703 2-s2.0-77952112006 10.1016/S0140-6736(10)60491-6
9. Jauch E. C., Saver J. L., Adams H. P., Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 44 870 947 10.1161/STR.0b013e318284056a
10. Broderick J., Connolly S., Feldmann E., Hanley D., Kase C., Krieger D., Mayberg M., Morgenstern L., Ogilvy C. S., Vespa P., Zuccarello M., Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007 38 6 2001 2023 2-s2.0-34249785974 10.1161/STROKEAHA.107.183689 (Pubitemid 46850654)
11. Hill M. D., Lye T., Moss H., Barber P. A., Demchuk A. M., Newcommon N. J., Green T. L., Kenney C., Cole-Haskayne A., Buchan A. M., Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003 60 9 1525 1527 2-s2.0-0037988721 (Pubitemid 36554818)
12. Shaw C. M., Alvord E. C. Jr., Berry R. G., Swelling of the brain following ischemic infarction with arterial occlusion. Archives of Neurology 1959 1 161 177 2-s2.0-0000326042
13. Hacke W., Schwab S., Horn M., Spranger M., de Georgia M., von Kummer R., 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Archives of Neurology 1996 53 4 309 315 2-s2.0-0029914446 (Pubitemid 26110085)
14. Wijdicks E. F. M., Diringer M. N., Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clinic Proceedings 1998 73 9 829 836 2-s2.0-0031692471 (Pubitemid 28411325)
15. Kasner S. E., Demchuk A. M., Berrouschot J., Schmutzhard E., Harms L., Verro P., Chalela J. A., Abbur R., McGrade H., Christou I., Krieger D. W., Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001 32 9 2117 2123 2-s2.0-0034827881 (Pubitemid 32868110)
16. Vahedi K., Hofmeijer J., Juettler E., Vicaut E., George B., Algra A., Amelink G. J., Schmiedeck P., Schwab S., Rothwell P. M., Bousser M. G., van der Worp H. B., Hacke W., Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurology 2007 6 3 215 222 2-s2.0-33846892907 10.1016/S1474-4422(07)70036-4 (Pubitemid 46237760)
17. Huttner H. B., Schwab S., Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. The Lancet Neurology 2009 8 10 949 958 2-s2.0-69849084036 10.1016/S1474-4422(09) 70224-8
18. Schwarz S., Schwab S., Bertram M., Aschoff A., Hacke W., Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998 29 8 1550 1555 2-s2.0-0031928556 (Pubitemid 28365572)
19. Kamel H., Navi B. B., Nakagawa K., Hemphill J. C., Ko N. U., Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Critical Care Medicine 2011 39 3 554 559 2-s2.0-79952189224 10.1097/CCM.0b013e318206b9be
20. Simard J. M., Chen M., Tarasov K. V., Bhatta S., Ivanova S., Melnitchenko L., Tsymbalyuk N., West G. A., Gerzanich V., Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke. Nature Medicine 2006 12 4 433 440 2-s2.0-33645733773 10.1038/nm1390
21. Simard J. M., Tsymbalyuk N., Tsymbalyuk O., Ivanova S., Yurovsky V., Gerzanich V., Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 2010 41 3 531 537 2-s2.0-77649132891 10.1161/STROKEAHA.109.572644
22. Simard J. M., Woo S. K., Schwartzbauer G. T., Gerzanich V., Sulfonylurea receptor 1 in central nervous system injury: a focused review. Journal of Cerebral Blood Flow & Metabolism 2012 32 9 1699 1717 10.1038/jcbfm.2012.91
23. Leonardi-Bee J., Bath P. M. W., Phillips S. J., Sandercock P. A. G., Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002 33 5 1315 1320 2-s2.0-0036093482 10.1161/01.STR.0000014509.11540.66 (Pubitemid 34517053)
24. Sandset E. C., Bath P. M. W., Boysen G., Jatuzis D., Kõrv J., Lüders S., Murray G. D., Richter P. S., Roine R. O., Terént A., Thijs V., Berge E., The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. The Lancet 2011 377 9767 741 750 2-s2.0-79952103780 10.1016/S0140-6736(11)60104- 9
25. Rordorf G., Koroshetz W. J., Ezzeddine M. A., Segal A. Z., Buonanno F. S., A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001 56 9 1210 1213 2-s2.0-0035826772 (Pubitemid 32405717)
26. Chestnut R. M., Temkin N., Carney N., A trial of intracranial-pressure monitoring in traumatic brain injury. The New England Journal of Medicine 2012 367 26 2471 2481 10.1056/NEJMoa1207363
27. Frank J. I., Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995 45 7 1286 1290 2-s2.0-0029088977
28. Schwab S., Aschoff A., Spranger M., Albert F., Hacke W., The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996 47 2 393 398 2-s2.0-0029810018 (Pubitemid 26324033)
29. Keller E., Steiner T., Fandino J., Schwab S., Hacke W., Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients: lessons from a preliminary study. Journal of Neurosurgical Anesthesiology 2002 14 2 130 136 2-s2.0-0036210365 10.1097/00008506-200204000- 00007 (Pubitemid 34266741)
30. Lindsberg P. J., Roine R. O., Advances in stroke 2003: hyperglycemia in acute stroke. Stroke 2004 35 2 363 364 2-s2.0-0842289216 10.1161/01.STR. 0000115297.92132.84 (Pubitemid 38174407)
31. Capes S. E., Hunt D., Malmberg K., Pathak P., Gerstein H. C., Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001 32 10 2426 2432 2-s2.0-0034800666 (Pubitemid 32954818)
32. NICE-SUGAR Study Investigators, Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 2009 360 13 1283 1297
33. Choi H. A., Ko S. B., Presciutti M., Fernandez L., Carpenter A. M., Lesch C., Gilmore E., Malhotra R., Mayer S. A., Lee K., Claassen J., Schmidt J. M., Badjatia N., Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocritical Care 2011 14 3 389 394 2-s2.0-79955797360 10.1007/s12028-010-9474-7